MHRA Class 4 Medicines Defect Notification: Clobazam 5mg/5ml and 10mg/5ml oral suspension 150ml (Martindale Pharmaceuticals Ltd)
MHRA Class 4 Medicines Defect Notification: Clobazam Martindale Pharma 5 mg/5 mL and 10 mg/5 mL Oral Suspension 150ml (Martindale Pharmaceuticals Ltd) Drug alert number: EL(26)A/38 Date issued: 17 September 2026 Martindale Pharmaceuticals has informed the MHRA of an error with the linear barcode of some batches of Clobazam 5mg/5mL and 10mg/5mL Oral Suspension 150mL. DMRC [...]
The post MHRA Class 4 Medicines Defect Notification: Clobazam 5mg/5ml and 10mg/5ml oral suspension 150ml (Martindale Pharmaceuticals Ltd) appeared first on Community Pharmacy England.
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest